STAGE IB BREAST CANCER

This large study tested whether temporarily shutting down the ovaries and adding different hormone-blocking drugs could better prevent breast cancer from returning compared to standard treatment alone. It involved over 3,000 premenopausal women who had surgery for hormone-sensiti…

This study tested whether a shorter, more intense 9-day radiation schedule works as well as the standard 6-8 week treatment for early-stage breast cancer. It involved 102 patients who had undergone lumpectomy, aiming to see if the shorter treatment controls cancer equally while p…

This study tested a two-drug combination (fulvestrant and palbociclib) to control breast cancer in patients aged 70 and older who could not undergo surgery due to frailty or who refused it. The goal was to see if this non-surgical approach could keep the cancer from growing for a…

This small, completed study tested whether a short, highly targeted course of radiation given before surgery was a safe and practical option for older women with early-stage, hormone-sensitive breast cancer. The goal was to see if this approach could shrink the tumor and potentia…

This study tested whether adding a breast MRI scan to the standard pre-surgery imaging (mammogram and ultrasound) helps doctors plan better surgery for women with early-stage breast cancer. It aimed to see if the extra scan leads to fewer cancer recurrences, fewer repeat surgerie…

This small, early study tested whether short-term use of anti-inflammatory drugs—fish oil capsules or the medication celecoxib—could change the biology of breast cancer diagnosed around pregnancy. Researchers gave one of these treatments to 42 young women for 1-3 weeks before the…